Valuation: Ipca Laboratories Limited

Market Cap 47TCr 485.41Cr 424.89Cr 392.77Cr 362.61Cr 682.82Cr 696.08Cr 4.69TCr 1.84TCr 23TCr 1.82TCr 1.78TCr 79TCr P/E 2027 *
33.5x
P/E 2028 * 28.1x
Enterprise Value 46TCr 473.11Cr 414.13Cr 382.82Cr 353.43Cr 665.53Cr 678.45Cr 4.57TCr 1.79TCr 22TCr 1.78TCr 1.74TCr 77TCr EV / Sales 2027 *
4.23x
EV / Sales 2028 * 3.69x
Free-Float
54.92%
Yield 2027 *
0.31%
Yield 2028 * 0.34%
1 day+0.94%
1 week+3.25%
Current month+8.20%
1 month+16.26%
3 months+26.84%
6 months+22.06%
Current year+29.71%
1 week 1,741
Extreme 1741
1,850.5
1 month 1,530
Extreme 1530
1,850.5
Current year 1,391.8
Extreme 1391.8
1,850.5
1 year 1,251.6
Extreme 1251.6
1,850.5
3 years 775.05
Extreme 775.05
1,850.5
5 years 669.8
Extreme 669.8
1,850.5
10 years 200
Extreme 200
1,850.5
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Date Insider Type Main position Quantity % Market Cap.
19/24/19Sell 40,00,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
+0.94%+3.25%+26.96%+139.25% 483.3Cr
-2.48%-6.72%+44.19%+156.43% 1,05400Cr
-1.52%-5.01%+61.87%+58.79% 62TCr
-1.30%-3.88%+27.81%+79.97% 44TCr
-1.12%-1.45%+27.34%+22.20% 32TCr
-1.73%-2.14%+27.22%+44.70% 28TCr
-1.95%-12.31%+18.32%+19.69% 26TCr
-1.45%-0.44%-27.17%-38.86% 22TCr
-1.44%-3.49%+19.60%+56.20% 19TCr
-1.04%-4.63%+16.01%+68.47% 16TCr
Average -0.67%-1.30%+24.21%+60.68% 35.61TCr
Weighted average by Cap. -0.39%-1.68%+33.43%+77.38%

Financials

2027 *2028 *
Net sales 11TCr 111.95Cr 98Cr 91Cr 84Cr 157.48Cr 160.54Cr 1.08TCr 423.57Cr 5.26TCr 420.48Cr 411.18Cr 18TCr 12TCr 124.83Cr 109.27Cr 101.01Cr 93Cr 175.6Cr 179.01Cr 1.21TCr 472.31Cr 5.87TCr 468.87Cr 458.49Cr 20TCr
Net income 1.4TCr 15Cr 13Cr 12Cr 11Cr 20Cr 21Cr 140.61Cr 55Cr 684.28Cr 55Cr 53Cr 2.36TCr 1.67TCr 17Cr 15Cr 14Cr 13Cr 24Cr 25Cr 167.7Cr 66Cr 816.1Cr 65Cr 64Cr 2.82TCr
Net Debt -1.18TCr -12Cr -11Cr -9.95Cr -9.18Cr -17Cr -18Cr -118.76Cr -47Cr -577.93Cr -46Cr -45Cr -1.99TCr -2.37TCr -25Cr -22Cr -20Cr -18Cr -35Cr -35Cr -237.64Cr -93Cr -1.16TCr -92Cr -90Cr -3.99TCr
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
14/26/14 ₹1,840.40 +0.94% 2,41,497
13/26/13 ₹1,823.30 +1.98% 3,41,668
10/26/10 ₹1,787.90 +0.99% 1,46,840
09/26/09 ₹1,770.40 +0.45% 96,723
08/26/08 ₹1,762.40 -1.71% 1,66,406
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,840.40INR
Average target price
1,733.50INR
Spread / Average Target
-5.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock